INTRONA, ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 524
NA - Nord America 459
EU - Europa 116
Totale 1.099
Nazione #
HK - Hong Kong 472
US - Stati Uniti d'America 458
SE - Svezia 42
CN - Cina 36
IT - Italia 24
DE - Germania 19
GB - Regno Unito 16
SG - Singapore 7
VN - Vietnam 6
FR - Francia 5
BE - Belgio 4
PL - Polonia 3
CA - Canada 1
FI - Finlandia 1
IE - Irlanda 1
IN - India 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
RO - Romania 1
Totale 1.099
Città #
Chandler 75
Fairfield 66
Woodbridge 45
Ashburn 41
Nyköping 36
Seattle 33
Wilmington 25
Cambridge 23
Houston 19
Ann Arbor 17
Beijing 11
New York 11
Boardman 9
Lawrence 9
Roxbury 9
Dong Ket 6
Inglewood 6
Bari 5
Des Moines 5
Nanjing 5
Brussels 4
Conversano 4
Guangzhou 4
London 4
Marseille 4
Mottola 4
Brooklyn 3
Shanghai 3
Taranto 3
Hong Kong 2
Hounslow 2
Lucera 2
Milan 2
Redmond 2
Redwood City 2
Singapore 2
St Albans 2
West Jordan 2
Yiwu 2
Dearborn 1
Dublin 1
Edinburgh 1
Hebei 1
Hefei 1
Helsinki 1
Kilburn 1
Los Angeles 1
Martina Franca 1
Nuremberg 1
Paris 1
Princeton 1
Pune 1
San Diego 1
Shenyang 1
Shenzhen 1
Southwark 1
Tianjin 1
Toronto 1
Vientiane 1
Wuhan 1
Wuxi 1
Totale 531
Nome #
Adherence to riluzole in patients with amyotrophic lateral sclerosis: An observational study 598
Corrigendum: Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 132
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis 112
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 81
Multiparametric unconventional MRI study in early stage of ALS disease 77
Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype 41
Inclusion of motor evoked abnormalities in amyotrophic lateral sclerosis: a diagnostic algorithm to early classify lower motor neuron phenotypes 38
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience 34
Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients? 24
Exploring Aesthetic Perception in Impaired Aging: A Multimodal Brain—Computer Interface Study 9
Totale 1.146
Categoria #
all - tutte 3.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020160 27 6 3 15 16 9 13 17 15 9 23 7
2020/2021143 2 25 30 10 8 10 10 9 5 15 7 12
2021/2022571 3 8 11 4 4 6 3 9 4 4 13 502
2022/2023161 19 28 14 10 24 13 1 22 24 0 3 3
2023/202470 1 6 4 8 5 12 1 4 2 6 4 17
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 1.146